• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center


    NIH Positively Impacted by Stimulus Package
    Request for Mentors: 2010 DF/HCC CURE Program

    For the past eight years, DF/HCC has participated in the NCI Continuing Umbrella of Research (CURE) Program

    Winter eNews
    Improving cancer outcomes: What’s your policy?

    What do clinical investigators, statisticians, health care economists, and health services researchers have in common? They collaborate on outcomes research, says John Ayanian, MD, MPP (HMS/BWH), leader of the Outcomes Research Program at DF/HCC

    CanCORS: Understanding the reasons for cancer care disparities

    Jane Weeks, MD, MSc, ScM (DFCI), co-leader of the DF/HCC Outcomes Research Program, was convinced she knew why elderly patients with colorectal cancer were much less likely to receive adjuvant chemotherapy than were their younger counterparts

    First trial of multi-targeted inhibitor in patients with metastatic colorectal cancer

    Although the median survival rate for patients with metastatic colorectal cancer has doubled over the past decade, it remains only about 24 months

    DF/HCC Skin SPORE renewed

    The DF/HCC Skin SPORE, led by Thomas Kupper, MD (BWH), has been highly successful in creating cohesion in the Cutaneous Oncology and Melanoma program, sparking new collaborative grants, fostering innovative ideas in cancer research, and advancing the careers of junior investigators

Displaying results 134 to 140 out of 223